Characteristics of impaired endothelium-dependent relaxation of rat aorta after streptozotocin-induced diabetes

Acta Pharmacologica Sinica

Volumn 20, Issue 9, 1999, Pages 844-850

  Shen, Jian Zhong ^a   Zheng, Xiu Feng ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Acetylcholine; Bradykinin; Calcimycin; Calcium; Cyclopiazonic acid; Experimental diabetes mellitus; Nitric oxide; Nitroarginine; Thoracic aorta; Vascular endothelium

Indexed keywords

ACETYLCHOLINE; BRADYKININ; CALCIMYCIN; CYCLOPIAZONIC ACID; HISTAMINE; N(G) METHYLARGININE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ARTERY DILATATION; ARTICLE; DIABETIC ANGIOPATHY; DRUG EFFECT; DRUG RECEPTOR BINDING; MALE; NONHUMAN; RAT; SMOOTH MUSCLE RELAXATION; STREPTOZOCIN DIABETES; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; BRADYKININ; CALCIMYCIN; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; INDOLES; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; VASODILATOR AGENTS;

EID: 0032886445     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Helmut D. Endothelial dysfunction: clinical implications. Prog Cardiovasc Dis 1997; 39: 287-324.
2. Furchgott RF. The 1996 albert lasker medical research awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide. JAMA 1996; 276; 1186-8.
3. Moncada S, Palmer RMJ, Higgs A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43; 109-42.
4. Pieper GM, Siebeneich W, Roza AM, Jordan M, Adams MB. Chronic treatment in vivo with dimethylthiourea, a hydroxyl radical scavenger, prevents diabetes-induced endothelial dysfunction. J Cardiovasc Pharmacol 1996; 28: 741-5.
5. Fraccarollo PDD, Santostasi G, Maragno I. Impairment of endothelium-dependent but not of endothelium-independent dilatation in guinea-pig aorta rings incubated in the presence of elevated glucose. Br J Pharmacol 1997; 121: 972-6.
6. Zheng XF, Guan YY, Kwan CY. Cyclopiazonic acid causes endothelium-dependent relaxation in rat aorta. Acta Pharmacol Sin 1993; 14: 21-6.
7. 2+ in EDRF release in rat aorta. J Vase Res 1994; 31: 18-24.
8. 2+ -ATPase inhibitor, cyclopiazonic acid, possibly through nitric oxide formation. Br J Pharmacol 1994; 111; 655-62.
9. Kamata K, Hayashi T, Umeda F. Persistence of cyclopiazonic acid-induced endothelium-dependent vasodilatation in spontaneously hypertensive and streptozotocin-induced diabetic rats. Jpn J Pharmacol 1997; 73; 247-50.
10. Quilley J, Fulton D, McGiff JC. Hyperpolarizing factors. Biochem Pharmacol 1997; 54: 1059-70.
11. 2+ transient in vascular smooth muscle cells in coculture. J Biol Chem 1992; 267: 20377-82.
12. Putney JWJr, Bird GStJ. The signal for capacitative calcium entry. Cell 1993; 75: 199-201.
13. Fukao M, Hattori Y, Kanno M, Sakuma I, Kitabatake A. Thapsigargin and cyclopiazonic acid-induced endothelium-dependent hyperpolarization in rat mesenteric artery. Br J Pharmacol 1995; 115 (6): 987-92.
14. 2+ entry in freshly isolated rabbit aortic endothelial cells. J Vase Res 1997; 34: 196-207.
15. Mancusi G, Hutter C, Baumgartner Parzer S, Schmidt K, Schutz W, Sexl V. High-glucose incubation of human umbilical vein endothelial cells does not alter expression and function of G-protein alphar-subunits or of endothelial NO synthase. Biochem J 1996; 315 (Pt 1): 281-7.